Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Seng

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oncogene|October 26, 2005
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationJ Ying, H Li, T J Seng, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 12, 2000
Adaptive role of caloric intake on the degenerative disease processesR W Hart, R Dixit, J Seng, et al.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
The International Journal of Artificial Organs|July 15, 2017
Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patientsBenjamin J J Seng, Louis L Y Teo, Laura L Chan, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|September 1, 2025
[Analysis of clinical manifestations and genetic characteristics of a late-onset auditory neuropathy pedigree caused by a mitochondrial <i>MT-TS1</i> gene mutation m.7471dup]Y N Wang, T Zhang, H J Wang, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Oncogene|January 30, 2007
Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancerM R J Kohonen-Corish, N D Sigglekow, J Susanto, et al.
Microbiology Resource Announcements|November 22, 2023
Genome sequences of <i>Arthrobacter globiformis</i> B-2979 phages MidnightRain and GusanitaDevansh Bansal, Alexander Z Fazilat, Matthew V Genchev, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oncogene|October 26, 2005
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationJ Ying, H Li, T J Seng, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 12, 2000
Adaptive role of caloric intake on the degenerative disease processesR W Hart, R Dixit, J Seng, et al.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
The International Journal of Artificial Organs|July 15, 2017
Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patientsBenjamin J J Seng, Louis L Y Teo, Laura L Chan, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|September 1, 2025
[Analysis of clinical manifestations and genetic characteristics of a late-onset auditory neuropathy pedigree caused by a mitochondrial <i>MT-TS1</i> gene mutation m.7471dup]Y N Wang, T Zhang, H J Wang, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2014
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)T Dragovich, D Laheru, F Dayyani, et al.
Oncogene|January 30, 2007
Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancerM R J Kohonen-Corish, N D Sigglekow, J Susanto, et al.
Microbiology Resource Announcements|November 22, 2023
Genome sequences of <i>Arthrobacter globiformis</i> B-2979 phages MidnightRain and GusanitaDevansh Bansal, Alexander Z Fazilat, Matthew V Genchev, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Pageof 2